189 related articles for article (PubMed ID: 37837651)
21. Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
Rungkitwattanakul D; Ives AL; Harriott NG; Pan-Chen S; Duong L
J Chemother; 2022 Apr; 34(2):103-109. PubMed ID: 34424136
[TBL] [Abstract][Full Text] [Related]
22. Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime.
Chanderraj R; Admon AJ; He Y; Nuppnau M; Albin OR; Prescott HC; Dickson RP; Sjoding MW
JAMA Intern Med; 2024 May; ():. PubMed ID: 38739397
[TBL] [Abstract][Full Text] [Related]
23. A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Elliott BP; Tang MM; Madden JA; Markert RJ; Burdette SD; Pleiman CM; Speelmon EC
Intern Emerg Med; 2022 Jan; 17(1):91-99. PubMed ID: 34089468
[TBL] [Abstract][Full Text] [Related]
24. Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
Triffault-Fillit C; Mabrut E; Corbin K; Braun E; Becker A; Goutelle S; Chaudier P; Fessy MH; Dupieux C; Laurent F; Gunst S; Lustig S; Chidiac C; Ferry T; Valour F
J Antimicrob Chemother; 2020 Aug; 75(8):2299-2306. PubMed ID: 32407512
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis.
Chiu CY; Sarwal A
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109649
[No Abstract] [Full Text] [Related]
26. Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.
Quach HT; Esbenshade AJ; Zhao Z; Banerjee R
Pediatr Blood Cancer; 2019 Jul; 66(7):e27750. PubMed ID: 30989780
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
[No Abstract] [Full Text] [Related]
28. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
[TBL] [Abstract][Full Text] [Related]
29. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
Luther MK; Timbrook TT; Caffrey AR; Dosa D; Lodise TP; LaPlante KL
Crit Care Med; 2018 Jan; 46(1):12-20. PubMed ID: 29088001
[TBL] [Abstract][Full Text] [Related]
31. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
[TBL] [Abstract][Full Text] [Related]
32. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
33. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Holsen MR; Meaney CJ; Hassinger AB; Fusco NM
Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
Blevins AM; Lashinsky JN; McCammon C; Kollef M; Micek S; Juang P
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782987
[TBL] [Abstract][Full Text] [Related]
35. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
[TBL] [Abstract][Full Text] [Related]
36. Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Peyko V; Smalley S; Cohen H
J Pharm Pract; 2017 Apr; 30(2):209-213. PubMed ID: 26912532
[TBL] [Abstract][Full Text] [Related]
37. Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study.
Cook KM; Gillon J; Grisso AG; Banerjee R; Jimenez-Truque N; Phillips EJ; Van Driest SL
J Pediatric Infect Dis Soc; 2019 Jul; 8(3):221-227. PubMed ID: 29590376
[TBL] [Abstract][Full Text] [Related]
38. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
[TBL] [Abstract][Full Text] [Related]
39. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
Molina KC; Barletta JF; Hall ST; Yazdani C; Huang V
J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Burgess LD; Drew RH
Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
